Evaluation in man of bumetanide, a new diuretic agent.
D000328:Adult; D001565:Benzoates / Q000009:adverse effects / Q000494:pharmacology*; D002082:Butylamines / Q000009:adverse effects / Q000494:pharmacology; D002712:Chlorides / Q000652:urine; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000009:adverse effects / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D009994:Osmolar Concentration; D010647:Phenyl Ethers / Q000009:adverse effects / Q000494:pharmacology; D011188:Potassium / Q000652:urine; D012964:Sodium / Q000652:urine; D013449:Sulfonamides; D013997:Time Factors
D001565:Benzoates; D002082:Butylamines; D002712:Chlorides; D004232:Diuretics; D010647:Phenyl Ethers; D013449:Sulfonamides; D012964:Sodium; D011188:Potassium